Hester Biosciences Limited (HESTERBIO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs174.78 Million ≈ $1.89 Million USD) by net assets (Rs3.51 Billion ≈ $37.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hester Biosciences Limited (HESTERBIO) market capitalisation for the company's overall valuation and market capitalisation.

Hester Biosciences Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Hester Biosciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hester Biosciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hester Biosciences Limited ranked by their cash flow conversion efficiency. Explore Hester Biosciences Limited cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Camlin Fine Sciences Limited
NSE:CAMLINFINE
0.078x
Nova Lifestyle I
NASDAQ:NVFY
-0.140x
Adgar Investments and Development Ltd
TA:ADGR
0.019x
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
-0.103x
Skue Sparebank
OL:SKUE
0.056x
Jin Air Co Ltd
KO:272450
-0.104x
ST.GEORGE MINING LTD
F:S0G
N/A
Hexindo Adiperkasa Tbk
JK:HEXA
0.038x

Annual Cash Flow Conversion Efficiency for Hester Biosciences Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Hester Biosciences Limited from 2006 to 2025. View Hester Biosciences Limited stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs3.27 Billion
≈ $35.33 Million
Rs645.11 Million
≈ $6.98 Million
0.197x +24.27%
2024-03-31 Rs3.03 Billion
≈ $32.75 Million
Rs481.34 Million
≈ $5.21 Million
0.159x +96.92%
2023-03-31 Rs2.92 Billion
≈ $31.62 Million
Rs235.96 Million
≈ $2.55 Million
0.081x +145.00%
2022-03-31 Rs2.67 Billion
≈ $28.92 Million
Rs88.08 Million
≈ $952.55K
0.033x -86.61%
2021-03-31 Rs2.36 Billion
≈ $25.52 Million
Rs580.53 Million
≈ $6.28 Million
0.246x +32.67%
2020-03-31 Rs2.06 Billion
≈ $22.33 Million
Rs382.92 Million
≈ $4.14 Million
0.185x -30.32%
2019-03-31 Rs1.81 Billion
≈ $19.59 Million
Rs482.10 Million
≈ $5.21 Million
0.266x +1.48%
2018-03-31 Rs1.45 Billion
≈ $15.68 Million
Rs380.24 Million
≈ $4.11 Million
0.262x -6.41%
2017-03-31 Rs1.24 Billion
≈ $13.43 Million
Rs347.98 Million
≈ $3.76 Million
0.280x +51.04%
2016-03-31 Rs1.05 Billion
≈ $11.34 Million
Rs194.44 Million
≈ $2.10 Million
0.186x -34.69%
2015-03-31 Rs838.58 Million
≈ $9.07 Million
Rs238.21 Million
≈ $2.58 Million
0.284x +129.46%
2014-03-31 Rs762.88 Million
≈ $8.25 Million
Rs94.44 Million
≈ $1.02 Million
0.124x -26.51%
2013-03-31 Rs684.95 Million
≈ $7.41 Million
Rs115.37 Million
≈ $1.25 Million
0.168x -27.37%
2012-03-31 Rs610.60 Million
≈ $6.60 Million
Rs141.61 Million
≈ $1.53 Million
0.232x -14.56%
2011-03-31 Rs479.85 Million
≈ $5.19 Million
Rs130.26 Million
≈ $1.41 Million
0.271x -18.64%
2010-03-31 Rs408.64 Million
≈ $4.42 Million
Rs136.33 Million
≈ $1.47 Million
0.334x +57.34%
2009-03-31 Rs366.47 Million
≈ $3.96 Million
Rs77.71 Million
≈ $840.36K
0.212x -27.97%
2008-03-31 Rs334.69 Million
≈ $3.62 Million
Rs98.53 Million
≈ $1.07 Million
0.294x -30.04%
2007-03-31 Rs279.47 Million
≈ $3.02 Million
Rs117.60 Million
≈ $1.27 Million
0.421x +225.91%
2006-03-31 Rs136.48 Million
≈ $1.48 Million
Rs17.62 Million
≈ $190.56K
0.129x --

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic
Market Cap
$201.99 Million
Rs18.68 Billion INR
Market Cap Rank
#16602 Global
#856 in India
Share Price
Rs2195.60
Change (1 day)
-2.24%
52-Week Range
Rs1259.10 - Rs2545.00
All Time High
Rs3204.96
About

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more